Neuroprotective effects of metformin on cerebral ischemia‐reperfusion injury by regulating PI3K/Akt pathway
Abstract Metformin (Met) is a commonly used drug in the treatment of type 2 diabetes. Currently, it has been found that Met can effectively reduce the incidence of stroke and exert anti‐inflammatory effects. However, its role in ischemia‐reperfusion (I/R)‐induced nerve injury remains unclear. This s...
Hlavní autoři: | , , , , , , , |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
Wiley
2021-10-01
|
Edice: | Brain and Behavior |
Témata: | |
On-line přístup: | https://doi.org/10.1002/brb3.2335 |